1.
J Matern Fetal Neonatal Med
; 23 Suppl 3: 30-3, 2010 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20873974
RESUMO
Supraventricular tachycardia (SVT), being atrioventricular re-entry the underlying mechanism, is the most frequent tachyarrhythmia requiring a medical treatment in infants with no cardiac disease. The acute treatment of a single episode of SVT has generally an excellent prognosis. An antiarrhythmic prophylaxis of SVT recurrences is usually recommended during the first year of life. Although many efficient drugs are available for the SVT treatment, a careful risk-benefit analysis of each single case should suggest the correct drug choice.